Richard Furie, MD

Richard Furie, MD, is Chief of the Division of Rheumatology at Northwell Health.

Articles by Richard Furie, MD

Insights: Obinutuzumab Faces Integration Challenges, Long-Term Potential in Lupus Nephritis

ByLuke Halpern, Assistant Editor,Richard Furie, MD

March 11th 2025

Expert: Obinutuzumab Shows Promise in Lupus Nephritis, Reinforcing Role in High-Disease Patients

ByLuke Halpern, Assistant Editor,Richard Furie, MD

March 4th 2025

Obinutuzumab is effective in reducing proteinuria and preserving kidney function in lupus nephritis, with consistent benefits across high-disease activity subgroups.

Richard Furie, MD

Articles by Richard Furie, MD

Insights: Obinutuzumab Faces Integration Challenges, Long-Term Potential in Lupus Nephritis

Expert: Obinutuzumab Shows Promise in Lupus Nephritis, Reinforcing Role in High-Disease Patients

Latest Updated Articles

Trending on Pharmacy Times

Examining the Safety Profiles of SG and Pembrolizumab in ASCENT-04

The Unit-Based Pharmacist: Roles, Responsibilities, and Real Impact

Navigating the New Standard of Care: Patient Needs and the Pharmacist’s Critical Role in Perioperative MIBC Treatment

RSV Vaccination as a Public Health Priority: Protecting Communities Through Pharmacy Access

FDA Approves Pirtobrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia